Stratasan is a pioneering healthcare intelligence company that aims to provide hospitals and healthcare systems with actionable market insights to fuel informed decision-making and strategic growth. Founded in 2010, this innovative company has attracted significant attention in the industry due to its unique solutions that leverage a combination of robust software platforms and reality-based data analysis.
With a focus on Analytics, Big Data, Computing, and Data Analytics, Stratasan stands out as a key player in the healthcare analytics field. The company's proprietary platform and experienced team of healthcare strategic growth professionals, known as Spark Services, play a pivotal role in delivering intelligent market insights that support strategic growth across various crucial areas, including strategic planning, marketing, physician relations, and mergers and acquisitions.
One of the noteworthy milestones for Stratasan is the $26.00M Venture Round investment it secured on 10 July 2019. This substantial investment came from a group of distinguished investors, namely Blue Heron Capital, Fulcrum Equity Partners, Bridge Bank, and Frist Cressey Ventures.
By offering cutting-edge solutions and attracting substantial investments from prominent players in the industry, Stratasan has positioned itself as a company with significant growth potential and a promising future in the healthcare analytics space.
